Neuropace
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuropace and other ETFs, options, and stocks.About NPCE
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads.
CEOJoel D. Becker
CEOJoel D. Becker
Employees184
Employees184
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded1997
Founded1997
Employees184
Employees184
NPCE Key Statistics
Market cap539.75M
Market cap539.75M
Price-Earnings ratio-21.41
Price-Earnings ratio-21.41
Dividend yield—
Dividend yield—
Average volume332.28K
Average volume332.28K
High today$16.32
High today$16.32
Low today$15.70
Low today$15.70
Open price$15.96
Open price$15.96
Volume27.60K
Volume27.60K
52 Week high$18.98
52 Week high$18.98
52 Week low$7.56
52 Week low$7.56
Stock Snapshot
With a market cap of 539.75M, Neuropace(NPCE) trades at $16.21. The stock has a price-to-earnings ratio of -21.41.
On 2026-01-14, Neuropace(NPCE) stock traded between a low of $15.70 and a high of $16.32. Shares are currently priced at $16.21, which is +3.2% above the low and -0.7% below the high.
Neuropace(NPCE) shares are trading with a volume of 27.6K, against a daily average of 332.28K.
During the past year, Neuropace(NPCE) stock moved between $7.56 at its lowest and $18.98 at its peak.
During the past year, Neuropace(NPCE) stock moved between $7.56 at its lowest and $18.98 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NPCE. This list is generated using Robinhood data, and it’s not a recommendation.